 AstraZeneca PLC LON:AZN announced it has received EU approval for the US39bn 27.5bn acquisition of Alexion Pharmaceuticals, Inc., expected to complete in the third quarter. The pharma giant has already received approval in the US, Canada, Brazil, Russia and Japan but is still waiting for the green light from the UK. 